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Key points! Silent mating type information regulation 2 homologue 1 (SIRT1) activity and content
increased significantly in overload-induced hypertrophy.! SIRT1-mediated signalling through Akt, the endothelial nitric oxide synthase mediated
pathway, regulates anabolic process in the hypertrophy of skeletal muscle.! The regulation of catabolic signalling via forkhead boxO 1 and protein ubiquitination is SIRT1
dependent.! Overload-induced changes in microRNA levels regulate SIRT1 and insulin-like growth factor
1 signalling.
Abstract Significant skeletal muscle mass guarantees functional wellbeing and is important
for high level performance in many sports. Although the molecular mechanism for skeletal
muscle hypertrophy has been well studied, it still is not completely understood. In the present
study, we used a functional overload model to induce plantaris muscle hypertrophy by surgically
removing the soleus and gastrocnemius muscles in rats. Two weeks of muscle ablation resulted
in a 40% increase in muscle mass, which was associated with a significant increase in silent
mating type information regulation 2 homologue 1 (SIRT1) content and activity (P < 0.001).
SIRT1-regulated Akt, endothelial nitric oxide synthase and GLUT4 levels were also induced in
hypertrophied muscles, and SIRT1 levels correlated with muscle mass, paired box protein 7
(Pax7), proliferating cell nuclear antigen (PCNA) and nicotinamide phosphoribosyltransferase
(Nampt) levels. Alternatively, decreased forkhead box O 1 (FOXO1) and increased K48 poly-
ubiquitination also suggest that SIRT1 could be involved in the catabolic process of hypertrophy.
Furthermore, increased levels of K63 and muscle RING finger 2 (MuRF2) protein could also
be important enhancers of muscle mass. We report here that the levels of miR1 and miR133a
decrease in hypertrophy and negatively correlate with muscle mass, SIRT1 and Nampt levels. Our
results reveal a strong correlation between SIRT1 levels and activity, SIRT1-regulated pathways
and overload-induced hypertrophy. These findings, along with the well-known regulatory roles
that SIRT1 plays in modulating both anabolic and catabolic pathways, allow us to propose the
hypothesis that SIRT1 may actually play a crucial causal role in overload-induced hypertrophy of
skeletal muscle. This hypothesis will now require rigorous direct and functional testing.
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Introduction
Skeletal muscle is a dynamic organ that can change its
metabolic rate many fold during intensive contractions.
This organ reacts well to endurance training by increasing
mitochondrial biogenesis, promoting capillarization, and
enhancing oxidative enzyme activities (Holloszy, 1967;
Davies et al. 1981;Marton et al. 2015). Due to the dynamic
characteristics of skeletalmuscle, bed rest, immobilization,
ageing and different types of muscle diseases often result
in muscle atrophy. Since muscle mass is closely related
to force-generating capacity (Goldspink, 1999), training
that stimulates hypertrophy is often used in elite sports
to enhance performance, or in recreational activities, to
improve quality of life.
The increase in multi-nucleated myocytes that results
from resistance training can also readily bring about an
increase in size. Hypertrophy requires the activation of
anabolic processes and also, possibly, the suppression
of catabolic processes. Exercise of a relatively high
load can often lead to micro trauma, due to high
tension. This, in turn, activates satellite cells resulting
in efficient tissue repair, which could be one of the
initiating steps of muscle hypertrophy (Viles & Powell,
1981; Shepstone et al. 2005). During the activation of
stem cells or satellite cells, there is an increased energy
requirement to synthesize macromolecules and maintain
an acceptable level of autophagy (Tang & Rando, 2014).
Because silent mating type information regulation 2
homologue 1 (SIRT1) is one of the regulators of auto-
phagy, down-regulation of SIRT1 delays activation of
satellite cells and probably the regeneration of skeletal
muscle (Tang & Rando, 2014). Indeed, SIRT1 has been
shown to regulate energy metabolism during myo-
genesis (Nedachi et al. 2008). The acetylation levels of
H4K16 can readily affect the transcription of certain
muscle-specific genes, and these lysine residues are
deacetylated by SIRT1. It is reported that inactivation
of SIRT1 deacetylase activity results in reduced myofibre
size, as well as in regeneration and depression of certain
genes important to muscle development (Ryall et al.
2015).
SIRT1 is a sensitive modulator of metabolic processes,
regulating fat and sugar metabolism (Canto et al. 2009;
Han et al. 2013; Banerjee et al. 2016). Generally, it is
believed that SIRT1 is activated during caloric restriction,
whenanabolicpathways aredown-regulated.However, the
results of a recent study indicate that SIRT1 could increase
protein synthesis in a cell type-dependent manner,
through mammalian target of rapamycin complex 1
(mTORC1) signalling (Igarashi & Guarente, 2016).
SIRT1 can also interact with peroxisome proliferator-
activated receptor gamma coactivator (PGC-1α), which
is the master regulator of mitochondrial biogenesis.
The results of a recent study suggest that hypertrophy
and mitochondrial biogenesis can occur simultaneously
(Scheffler et al. 2014) although the increases in
mitochondrial mass are not associated with increased
aerobic capacity (Scheffler et al. 2014). It is generally
believed that activation of PGC-1α is an adaptive response
to endurance training, but apparently resistance training
can also activate PGC-1α via one of the isoforms of this
co-activator. It iswell known that the activationof PGC-1α
is isoform-specific (Yoshioka et al. 2009) as is regulation
of the PGC-1α1, PGC-1α2 and PGC-1α3 genes, while the
PGC-1α4 gene exhibits a very different regulation profile
(Ruas et al. 2012). PGC-1α4 shares the same alternative
exon1 with PGC-1α2 and has the same N-terminus,
but its mRNA structure is different as it contains a
31 nucleotide insertion between exons 6 and 7, which
generates a premature stop codon. Moreover, PGC1α4
encodes a 266 amino acid protein whose molecular
weight is 29.1 kDa, whereas the molecular weights of
other PGC1-α protein isoforms are all around 41 kDa.
Interestingly, insulin-like growth factor 1 (IGF-1) and
mammalian target of rapamycin (mTOR)pathways,which
are very important for muscle hypertrophy, are activated
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by PGC-1α4. It was indicated that both endurance and
resistance training have to activate PGC-1α, which appears
to be the ultimate exercise-regulated protein (Ruas et al.
2012).
In addition to the PGC-1α–SIRT1 interaction, SIRT1
can also influence nitric oxide (NO) signalling and end-
othelial nitric oxide synthase (eNOS) activity, which
is regulated by acetylation/deacetylation, and SIRT1
has been shown to deacetylate K496 and K506 in
the structure of eNOS (Mattagajasingh et al. 2007).
The SIRT1-mediated upregulation of eNOS can induce
mitochondrial biogenesis (Csiszar et al. 2009) and NO
is also important for the proliferation of satellite cells
(Anderson, 2000). Moreover, NO mediates the signalling
cascade via guanylate cyclase and the generation of cyclic
guanosine monophosphate (cGMP) can induce follistatin
expression (Pisconti et al. 2006), which can also affect
muscle hypertrophy. Follistatin is an antagonist of myo-
statin, which is a negative regulator of skeletal muscle
mass. Indeed, activation of follistatin has been shown to
inhibit the activity of myostatin and result in hypertrophy
(Lee & McPherron, 2001). Moreover, follistatin-like 1
(Fstl1) protein, which belongs to the follistatin family,
can activate Akt/eNOS signalling and modulate protein
synthesis (Ouchi et al. 2008).
The need for increased protein synthesis during muscle
hypertrophy is associated with a significant activation of
muscle-specific genes and large increases in mRNA levels.
However, not all mRNAs transcribed result in protein
assembly, due to the many different post-transcriptional
control systems that exist in cells.
MicroRNAs (miRNAs) are short, single stranded,
non-coding RNA molecules that negatively regulate their
targets at the post-transcriptional level by pairing their
nucleotides 2–8 at the 5′ end, leading to either mRNA
degradation or translational repression. It is suggested
that miRNAs could play a crucial role in skeletal muscle
development, and myogenesis (Lu et al. 2012). MirR1,
as an inhibitory molecule, suppresses the activity of the
transcriptional regulator, histone deacetylase 4, which
increases the activity of myocyte enhancer factor-2
which, in turn, facilitates cellular differentiation (Rao
et al. 2006). In addition, MyoD appears to suppress
the expression of some genes, including Fstl1, by the
activation of muscle- specific miR-206 (Rosenberg et al.
2006). Down-regulation of miR-133 resulted in increased
muscle fibre size and force generation following electrical
stimulation of skeletal muscle (Rhim et al. 2010),
indicating the importance of this miR in muscle function.
Also, SIRT1,which is apotential regulatorofmusclehyper-
trophy, is controlled by miRs (Buler et al. 2016).
In the present study, we investigated the role of SIRT1 in
overload-induced muscle hypertrophy in order to clarify
the importance of some molecular pathways and inter-
actions with signalling processes.
Methods
Animals
Middle aged (15 months) male Wistar rats (507 ± 33 g)
from the animal facility of the Research Institute of Sport
Science, University of Physical Education, were used in the
study and assigned to control (n = 6) and hypertrophied
(n = 7) groups. Animals were housed in a thermoneutral
environment (!22°C),ona12:12hphotoperiod, andwere
providedwith food andwater ad libitum. The investigation
was carried out according to the requirements of The
Guiding Principles for Care and Use of Animals, EU, and
approved by the local ethics committee, also conforming
to the principles ofUK regulations, as described inGrundy
(2015).
Muscle overload
All surgical procedures were performed under aseptic
conditions with the animals deeply anaesthetized with
pentobarbital sodium (50 mg kg−1 I.P.). Analgetics
(doliprane at a dose of 500 mg l−1 in drinking water)
was administered to the animals for 2 days following the
operation. Compensatory overload of the plantarismuscle
was performed bilaterally via removal of their major
synergistic muscles (gastrocnemius-medialis, -lateralis
and soleus), as described in detail previously (Baldwin
et al. 1982; Bigard et al. 2001; Chaillou et al. 2012).
Particular attention was made to ensure that plantaris
neural and vascular supplies were not damaged, and
the aponeuroses and skin were independently sutured. A
sham operation was systematically performed in control,
non-overloaded groups, which consisted of separating
tendons of the soleus and gastrocnemius muscles from
that of the plantarismuscle. Theoverload lasted for 14days
and the animals were continuouslymonitored throughout
the experimental period. At end of the overload period
the rats were killed via decapitation. The plantaris muscle
was carefully and quickly removed bilaterally, trimmed
of excess fat and connective tissue, wet weighed, frozen
in liquid nitrogen and stored at −80°C until subsequent
analysis.
Immunohistochemistry
Deparaffinized and rehydratedmuscle sections were auto-
claved for 5 min in 10 mM sodium citrate (pH 6.0) for
antigen retrieval. Endogenous peroxidase was inactivated
by incubation in 0.3%H2O2 inmethanol for 30minon ice.
After blocking in 10%normal goat serum (NGS), 2%BSA,
0.1%Triton-X100 in PBS for 30min at room temperature,
the sections were incubated with anti-Pax7 mouse mono-
clonal antibody (Development Studies Hybridoma Bank,
Iowa City, IA, USA) diluted 1:3 with 2% BSA in PBS at
37°C for 1 h. After washing with cold PBS, four times,
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sectionswere incubatedwith anti-mouseHRP-conjugated
sheep secondary antibody (GE Healthcare, Piscataway,
NJ, USA: NA931V) diluted 1:200 with 10% NGS, 2%
BSA in PBS. Following washing with cold PBS, four
times, ImmPACT DAB substrate kit (Vector Laboratories,
Burlingame, CA, USA: SK-4105) was used for detection.
The sections were counterstained with haematoxylin
(Muto Chemicals, Tokyo, Japan: 3000-2), dehydrated
and mounted with Multi Mount 480 (Matsunami Glass,
Osaka, Japan; FM48001). Negative control staining was
performed without primary antibody, as above. Images
of immunostained sections were captured by microscopy
(Keyence) with a 20×/0.75 PlanApo objective (Olympus).
Pax7-positive and -negative nuclei in each field were
counted. The percentage of Pax7-positive nuclei in each
group was calculated and the results were analysed by
one-way ANOVA.
Estimation of oxidant levels and redox active iron
Intracellular oxidant and redox-active iron levels
(Kalyanaraman et al. 2012) were estimated using
modifications of the dichlorodihydrofluorescein diacetate
(H2DCFDA) stainingmethod (Radak et al. 2004). In brief,
the H2DCFDA (Invitrogen-Molecular Probes, Carlsbad,
CA, USA; no. D399) was dissolved at a concentration of
12.5 mM in ethanol and kept at −80 °C in the dark. The
solution was freshly diluted with potassium phosphate
buffer to 125 µM before use. For fluorescence reactions,
96-well black microplates were loaded with potassium
phosphate buffer (pH 7.4) to a final concentration of
152 µM per well. Then 8 µl diluted tissue homogenates
and 40 µl 125 µM dye were added to achieve a final
dye concentration of 25 µM. The change in fluorescence
intensity was monitored every 5 min for 30 min with
excitation and emissionwavelengths set at 485 and 538 nm
(Fluoroskan Ascent FL). The fluorescence intensity unit
was normalized to the protein content and expressed in
relative units perminute. Thismethod does not accurately
measure the levels of all reactive oxygen species, nor does it
directly report hydrogen peroxide levels, but nevertheless
increased fluorescence intensity does give an indication
of a more oxidizing environment, typically enriched
in redox-active iron compounds (Kalyanaraman et al.
2012).
Western blots
Whole cell homogenates of the plantaris muscle
were generated by Ultra Turrax (IKA-Werke, Staufen,
Germany) homogenizer using 10 vol of lysis buffer
(137 mM NaCl, 20 mM Tris-HCl, pH 8.0, 2% NP-40, 10%
glycerol and protease inhibitors). Ten to 50 µg of protein
was electrophoresed on 8–12% (v/v) polyacrylamide
SDS-PAGE gels. Proteins were electrotransferred onto
PVDF membranes. The membranes were subsequently
blocked in 1–5% skimmed milk or BSA, and after
blocking, PVDF membranes were incubated at room
temperature with primary antibodies [Nampt 1:500
Abcam (Cambridge, MA, USA) no. ab37299, SIRT1
1:3000 Abcam no. ab110304, Acetyl-p53 (Lys373, Lys382)
1:1000 Millipore (Billerica, MA, USA) no. 06-758, Akt
1:1000 Cell Signaling (Danvers, MA, USA) no. 9272,
Phospho-Akt (Ser473) 1:1000 Cell Signaling no. 9271,
IR-beta 1:1000 Santa Cruz Biotechnology (Santa Cruz,
CA, USA) no. sc-711, Myf5 1:5000 Abcam no. ab125078,
MyoD 1:1000 Abcam no. ab126726, PCNA 1:500 Santa
Cruz no. sc-7907, eNOS 1:625 Abcam no. 76198, VEGF
1:1000 Santa Cruz no. sc-152, GLUT4 1:200 Santa Cruz
no. sc-7938, FOXO1 1:1000 Cell Signaling no. 9454,
K48-linkage Specific Polyubiquitin 1:1000 Cell Signaling
no. 8081S, K63-linkage Specific Polyubiquitin 1:1000
Cell Signaling no. 5621S, MuRF1 1:1000 Santa Cruz
no. sc-32920, MuRF2 1:500 Santa Cruz no. sc-49457,
Proteasome subunit alpha type-6 (PSMA6) 1:1200 Cell
Signaling no. 2459S, Bax 1:500 Santa Cruz no. 492,
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
1:10 000 Sigma-Aldrich (St Louis, MO, USA) no. G8795].
After incubation with primary antibodies, membranes
were washed in Tris-buffered saline-Tween-20 (TBST)
and incubated with HRP-conjugated secondary anti-
bodies (Jackson ImmunoResearch Europe, Newmarket,
UK). After incubation with secondary antibodies,
membranes were repeatedly washed. Membranes were
incubated with chemiluminescent substrate (Thermo
Scientific, Waltham, MA, USA; SuperSignal West Pico
Chemiluminescent Substrate no. 34080) and protein
bands were visualized on X-ray films. The bands
were quantified by ImageJ software, and normalized to
GAPDH, which served as an internal control.
Detection of mature miRNAs in skeletal muscle
TheTaqManmiRNA reverse transcriptase kit andTaqMan
miRNA assays (Applied Biosystems, Foster City, CA,
USA) were used to quantify mature miRNA expression
levels. Each target miRNA was quantified according to
the manufacturer’s protocol with minor modifications.
Briefly, reverse transcriptase reactions were performed
with miRNA-specific reverse transcriptase primers and
5 ng of purified total RNA for 30 min at 16°C, 30 min
at 42°C, and finally 5 min at 85°C to heat-inactivate
the reverse transcriptase. All volumes suggested in
the manufacturer’s protocol were halved, as previously
reported (Gallagher et al. 2010). Real-time PCRs for each
miRNA (10µl total volume) were performed in triplicate,
and each 10 µl reaction mixture included 2.4 µl of 10×
diluted reverse transcriptase product. Reactions were run
on a PRISM7900HTFast Real-TimePCRSystem (Applied
Biosystems) at 95°C for 10 min, followed by 40 cycles
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at 95°C for 15 s and 60°C for 1 min. Twofold dilution
series were performed for all target miRNAs to verify the
linearity of the assay. To account for possible differences in
the amount of starting RNA, all samples were normalized
to the small nuclear RNARNU48 (catalogue no. 4373383).
Importantly, compensatory hypertrophy did not alter
RNU48 quantities compared with control values (tested
against 18S rRNA). All reactions were run singleplex, in
triplicate, andquantifiedusing the cycle threshold (""Ct)
method (Livak & Schmittgen, 2001).
Quantitative reverse-transcription PCR validation
Eight miRNAs were selected to investigate their potential
role in muscle hypertrophy, using quantitative real-time
reverse-transcription PCR (qRT-PCR). TaqMan Micro-
RNA Assays were used as follows: miR-214, miR-206,
miR-23a, miR-34a, miR1, miR-133a, miR-128a and miR-
125b. All materials were supplied by Applied Biosystems.
Total RNA (10 ng) was reverse transcribed by the Micro-
RNA Reverse Transcription Kit (Applied Biosystems).
qRT-PCR was performed using TaqMan Fast Universal
PCR Master Mix on a 7500 Fast Real-Time PCR System
according to the manufacturer’s protocol. All samples
were run in triplicate. Normalized signal levels for
each miRNA were calculated using a comparative cycle
threshold method (ddCT method of Livak & Schmittgen,
2001) relative to the mean of miR-324-3p and miR-320b
following the manufacturer’s instructions (SDS Program;
Applied Biosystems).
Detection of mRNA levels
RNA isolation. RNA isolation was carried out by
the NucleoSpin RNA II kit (Macherey-Nagel,
Du¨ren, Germany; no. 740955.250) according to the
manufacturer’s instructions. Plantaris muscle samples
were thawed quickly on ice and added to buffer R1,
supplemented with β-mercaptoethanol and disrupted
with Ultra Turrax (IKA-Werke) for 60 s at high speed.
RNA was eluted by adding 60 µl RNase-free water to
columns.
cDNA synthesis. cDNA was synthesized using a Tetro
cDNA Synthesis kit (Bioline, Luckenwalde, Germany;
no. BIO-65026) in accordance with the manufacturer’s
instructions. Briefly, the reaction conditions were as
follows: 1 µg of RNA, 1 µl of random primers, 1 µl
of 10 mM dNTP, 1 µl of RNase inhibitor and 0.25 µl
of 200 U µl−1 reverse transcriptase in a final volume of
20 µl, and the solution was incubated for 10 min at 25°C,
primer annealing, followed by 42°C for 60 min, primer
elongation, and followed by 80°C for 5 min termination.
cDNA samples were stored at−20°C.
qRT-PCR. Based on the principle of the SybrGreen
detection method, EvaGreen dye (Biotium, Hayward, CA,
USA) was used to detect PCR products. The PCR was
performed using a primer pair specific for mRNA of
SIRT1 and IGF-1 isoforms (SIRT1-F: TCTGACTGGA
GCTGGGGTTTC, SIRT1-R: GACACAGAGATGGCTGG
AACT; IGF1-Ea-F: TTCAGTTCGTGTGTGGACCAAG,
IGF1-Ea-R: TCCACAATGCCCGTCTGTGGTG; IGF1-
Eb/MGF-F: TCCGCTGCAAGCCTACAAAGTC, IGF1-
Eb/MGF-R: CTTTCCTTCTCCTTTGCAGCTTCC). PCR
amplifications consisted of equal amounts of template
DNA, 10 µl of ImmoMix complete ready-to-use
heat-activated 2× reaction mix (Bioline), 1 µl of 20×
EvaGreen (Biotium), 2.5 µl of 10 nmol l−1 forward and
reverse primer (IBAGmbH, Go¨ttingen, Germany) and
water to a final volume of 20 µl. Amplifications were
performed in a Rotor-Gene 6000 thermal cycler (Corbett
Life Science/Qiagen, London, UK) at 95°C for 10 min,
followed by 40 cycles of 95°C for 10 s, 60°C for 20 s
and 72°C for 30 s in triplicate. The validity of the signal
was evaluated by melting analysis and agarose gel electro-
phoresis. The rat RPL13 gene served as an endogenous
control gene.
Assessment of SIRT1 activity
SIRT1 activity was determined using a SIRT1 Fluoro-
metric Kit (Enzo Life Sciences, Plymouth Meeting, PA,
USA; no. BML-AK555) (Barbosa et al. 2007). Briefly,
whole cell lysate from 200 mg plantaris muscle samples
was prepared by Dounce homogenizer (12 stokes) in
TKMS-NP40 buffer (50 mM Tris-HCl pH 7.4, 25 mM
KCl, 5 mM MgCl2, 0.25 mM sucrose, 0.5% NP40). Homo-
genates were filtered through one sheet of Miracloth filter
and sonicated on ice with Sonifier Cell Disruptor B-12
(Branson Sonic Power Company, Danbury, CT, USA)
five times for 20 s each. Samples were then centrifuged
at 15,000 g, for 15 min and supernatant was kept at
−80 C for further analysis. Then, 10 µl concentrated
sample, 0.5 mM NAD, 1 µl substrate and assay buffer
were mixed in a microplate at a final volume of 50 µl
and incubated at 30 C for 30 min. Using 1 U per well
recombinant, SIRT1 enzyme served as a positive control,
while no enzyme was added to the wells of negative
controls. Reactions were terminated by the addition
of a solution containing Fluor de Lys Developer and
2 mM nicotinamide. Values were determined by reading
fluorescence on a fluorometric plate reader (FluoroScan
Ascent FL, Thermo Scientific) with an excitation wave-
length of 355 nm and emission wavelength of 460 nm.
Endogenous SIRT1 activity was determined with the
exception that no enzyme was added to the reaction. The
data are expressed as a proportion of the total protein
content.
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NAD/NADH measurement
The measurement was performed by using an
NAD/NADHAssay Kit (Abcamno. ab65348) according to
the manufacturer’s instructions. Briefly, plantaris muscle
samples (<10 mg) were homogenized in NADH/NAD
extraction buffer and filtered through a 10 kDa Micro-
con cut off filter, then centrifuged and separated into
treated and untreated sample parts. Treated samples
underwent a heating procedure at 60°C for 30 min for
NAD decomposition. 50 µl diluted NADH standards and
samples were loaded into 96-wellmicroplates in duplicate.
Then, 100 µl Reaction Mix was added to all wells except
the background. After 5 min of incubation at room
temperature, 10 µl NADH developer was mixed into the
wells to generate colour changes. Optical density was read
at 450 nm every 5min for 1 h. The results were normalized
based on the initial tissue weight (Goldspink, 1999).
Statistical analyses
Statistical significance was assessed by the two-sample t
test. Correlation matrices were applied to evaluate the
relationship between different variables. Significance level
was set at P< 0.05.
Results
Fourteen days of overload resulted in more than a 40%
increase in the mass of the plantaris muscles (P < 0.01)
(Fig. 1A). The actual number of muscle fibres was not
changed by hypertrophy (Fig. 1B). Satellite cells are
proliferating undifferentiated cells, expressing paired-box
transcription factors, Pax3 and Pax7. Pax7 genes are
crucial to myogenic cells due to their activation of muscle
regulatory factors. It has been suggested that growth and
repair of skeletal muscle is dependent on Pax7, and the
level of Pax7-positive cells increased in the overloaded
group (Fig. 1C). The levels of myogenic regulatory factor
MyoD and proliferating cell nuclear antigen (PCNA),
which correlate with DNA synthesis during the cell cycle,
were also elevated in the overloaded group (P < 0.01)
(Fig. 1D and E).
The increases in muscle hypertrophy were strongly
associated with increased levels of SIRT1 mRNA
(P < 0.05), protein (P < 0.01) and activity (P < 0.01)
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Figure 1. Overload resulted in increased muscle mass, and enhanced levels of MyoD, PCNA and Pax7
Plantaris muscle mass (A), number of muscle fibres per photo field (B), number of Pax7+ cells/100 fibres (C), and
MyoD1 (D) and PCNA (E) protein levels. Results are expressed as mean ± SD (Control: n = 6, Hypertrophy: n = 7).
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(Fig. 2A–C). Concomitantly, the acetylation of p53
decreased significantly (P < 0.01), a validating result
that would be predicted from the increased SIRT1
levels (Fig. 2D). Because Nampt is important for NAD
biosynthesis, and because NAD is required for SIRT1
activity, the levels of Nampt were measured and found
to increase similarly in the overloaded group as measured
relative to activity and protein content of SIRT1 (Fig. 3A).
Interestingly, NAD levels did not change significantly
(Fig. 3B), while NADH levels and approximate cellular
oxidation state decreased in the overloaded group (Fig. 3C
and D). The crude levels of reactive oxygen species (ROS)
was assessed byH2DCFDA fluorescence (Fig. 3D), and the
data indicate that the ROS levels are lower 2 weeks after
the ablation of soleus and gastrocnemius muscles. The
exact measurement of specific ROS is not possible by this
method, but the overall assessment of ROS induction can
be performed effectively using H2DCFDA.
The levels of some of the SIRT1 signalling proteins,
includingAkt1 and eNOS, also increased in the overloaded
groups (Fig. 4A and B). The overload-induced increase
in GLUT4 content (Fig. 4C) suggests up-regulation
of sugar uptake during hypertrophy. On the other
hand, overload decreased the levels of FOXO1 and K48
polyubiquitination (Fig. 5A and B) and increased protein
content of proteasome subunit PSMA6 and MuRF2
(Fig. 5C and D) and K63 ubiquitination (Fig. 5E). The
level of MuRF1 (Fig. 5F) was unchanged by hypertrophy.
The level of miR1, which potentially down-regulates
IGF-1 (Hu et al. 2013), decreased in the overloaded
model (Fig. 6A). Indeed, this decrease was associated with
increased levels of IGF-1Ea and mechano-growth factor
mRNA (r2 = −0.818, −0.774, P < 0.05) (Fig. 6B and C).
Along with mechano-growth factor, IGF-1 is important
to satellite cell proliferation, differentiation and muscle
growth (Allen & Boxhorn, 1989).
The levels of some important miRNAs in control and
overloaded skeletal muscles were measured. The data
revealed that miR1 and miR133a levels decreased with
mechanical overload, while the levels of miR23a, miR34a,
miR125b and miR214 increased significantly (Fig. 7). By
contrast, the levels ofmiR128a andmiR206 did not change
significantly.
Discussion
The present investigation reveals novel information on
overload-induced hypertrophy of skeletal muscle. SIRT1
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Figure 2. Muscle hypertrophy was associated with increased content and activity of SIRT1
SIRT1 mRNS level (A), SIRT1 protein level (B), SIRT1 activity (C) and Ac-p53 protein level (D). Two weeks of
compensatory hypertrophy significantly increased the content and activity of SIRT1 and the acetylation level of
p53. Results are expressed as mean ± SD (Control: n = 6, Hypertrophy: n = 7). ∗P < 0.05, ∗∗P < 0.01.
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appears to play an important role in muscle hyper-
trophy. To our knowledge, there is only one other study
which showed that SIRT1 is involved in the hyper-
trophy of skeletal muscle. In the protocol of Lee &
Goldberg (2013) fastingwas used to investigate howSIRT1
regulates atrophy-associated genes. The investigators
found that after 4 days of fasting, SIRT1 content decreased
significantly, and this was associated with increased levels
of atrogin1 and MuRF1. On the other hand, when
they overexpressed SIRT1 with electroporation, most of
the atrogenes were inhibited. Therefore, they concluded
that induction of SIRT1 resulted in muscle hypertrophy
through the inactivation of downstream FOXOs (Lee
& Goldberg, 2013). Our experimental model was very
different, as we used compensatory hypertrophy, which
increased the mass of the plantaris muscle by some 40%.
In our model, the SIRT1 protein content and activity
increased significantly in theoverloadedmuscle alongwith
eNOS and Akt content.
SIRT1 regulates the activity of eNOS and Akt by
deacetylation (Mattagajasingh et al. 2007; Sundaresan et al.
2011) and thus SIRT1 is linked to both NO production
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Figure 3. Mechanical overload increased NAMPT and decreased NADH and redox-active iron levels
PBEF/Nampt protein level (A), NAD+ level (B), NADH level (C) and intracellular oxidant and redox-active iron
estimated from dichlorodihydrofluorescein diacetate (H2DCFDA) fluorescence levels (D) can alter the activity of
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and protein synthesis. At very low concentrations, NO
can actually be regarded as an antioxidant (Lundberg
et al. 2008) and this could, at least in part, explain
why the cellular oxidation level (and redox-active iron)
decreased in all overloaded muscles. Lower levels of
oxidants result in a reduced redox microenvironment,
which has been shown to be beneficial to myogenesis,
at least in cell culture (Hansen et al. 2007). However, it
must be mentioned that the role of various free radicals
and other reactive oxygen and nitrogen species in myo-
genesis could be dependent on the actual levels of such
species (Vasilaki& Jackson, 2013).TheSIRT1–eNOS inter-
action may therefore be important to optimize oxidant
levels to myogenesis and muscle hypertrophy. Moreover,
SIRT1 appears to be important for the activation of
cellular growth. Indeed, SIRT1 activates Akt proteins,
which appears to have important anti-apoptotic effects
(Wang et al. 2013). SIRT1 up-regulates genes involved in
cell metabolism and growth factor signalling, including
Akt (Rafalski et al. 2013). Theoretically, reduced apoptosis
would help increase muscle mass. Moreover, Akt is not
just an activating protein for synthetic pathways, but
also suppresses catabolic processes via down-regulation of
FOXO1 (Stitt et al. 2004). SIRT1 can directly deacetylate
FOXO1 and decrease the activity of this protein (Lee &
Goldberg, 2013).
Age-related loss of muscle mass is associated with
decreased activity of SIRT1 (Koltai et al. 2012), and
it has been shown that aerobic treadmill running
increased the activity of SIRT1 and enhanced anabolic
pathways in skeletal muscle (Ziaaldini et al. 2015).
In accordance with these data, inhibition of poly
[ADP-ribose] polymerase (PARP-1) preserved NAD+
levels in aged skeletal muscle and enhanced the activity of
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Figure 4. Muscle hypertrophy increased the levels of Akt, eNOS and GLUT4 proteins
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SIRT1 and resulted in increased mitochondrial biogenesis
and performance (Mohamed et al. 2014). Moreover,
ageing is often associated with increased inflammation
and the induction of inducible nitric oxide synthase
(iNOS) and S-nitrosylation of SIRT1, causing inhibition
of this enzyme. Inhibition of SIRT1 activity leads to
enhanced acetylation of the p53 and p65 subunits of
nuclear factor kappa B (NF-kB), whichmay be responsible
for sarcopenia-associated inflammation (Shinozaki et al.
2014).
Muscle atrophy caused by unloading was prevented
by resveratrol treatment through activation of SIRT1,
attenuating the loss of muscle force (Momken et al.
2011). Moreover, resveratrol supplementation in C2C12
cells has been shown to induce hypertrophy through Akt
and extracellular signal-regulated kinase (Erk) activation
(Montesano et al. 2013). SIRT1 activity was not measured
in this study, but because resveratrol readily activates
SIRT1, it appears that SIRT1 activators are potential
pharmacological tools to attenuate muscle atrophy.
SIRT1 is dependent on NAD+ levels, while the
biosynthesis of NAD+ from nicotinamide (NAM), in
mammals, is catalysed by phosphoribosyltransferase
(Nampt). It has been shown that depletion of Nampt
decreases the levels of SIRT1 (Pillai et al. 2005), and
therefore Nampt availability is crucial for NAD+ levels
and activity of SIRT1. In the present experimental
model, overloading resulted in significant elevation of
Nampt levels, suggesting elevated NAD generation. One
of the hypotheses for the current investigation was
that NO-mediated satellite cell proliferation and then
differentiation is necessary for the hypertrophy of skeletal
muscle.
Data from genetically modified animal models yielded
contrasting results on the role of satellite cells in muscle
hypertrophy (Oustanina et al. 2004;McCarthy et al. 2011).
However, even the paper byMcCarthy et al. (2011), which
questions the role of satellite cells in hypertrophy, showed
that the ablation of satellite cells halted the increase in
myonuclei with hypertrophy and regeneration of fibres.
Moreover, it has been shown that SIRT1 stimulates the
proliferation of satellite cells (Rathbone et al. 2009), which
are the primary source of nuclei for skeletal muscle and
are required for growth and repair of this tissue (Conboy
et al. 2005). This observation does not contradict an earlier
finding which states that SIRT1 inhibits differentiation of
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Figure 5. Overload significantly altered the levels of FOXO1, K48 polyubiquitination, PSMA6, MuRF2,
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satellite cells (Fulco et al. 2008), as proliferation is an earlier
step in the process of tissue growth and repair.
The differentiation, and the associated increase in
protein synthesis, requires a great deal of energy.
Therefore, the energy state of the cells could be a limiting
factor. Indeed, it has been shown that glucose restriction
results in depletion of NAD+ and Nampt levels and
decreased activity of SIRT1, which was associated with
impaired myogenesis (Fulco et al. 2008). The increased
need for energy to cover anabolic processes is supported
by the finding that GLUT4 content was increased in
our hypertrophy model, in accordance with findings of
earlier studies (Kruger et al. 2013; Christoffolete et al.
2015).
Protein ubiquitination (Ub) could be a marking step
for proteasome system-mediated protein degradation.
K48-linked Ub chains target proteins to 26S proteasomes,
but K63-linked chains are not degraded by proteasomes
because themain cellular proteins that associate selectively
with K63 chains block their binding to proteasomes
(Nathan et al. 2013). K48 degradation decreased
in the hypertrophied muscle, indicating suppressed
degradation, while K63 ubiquitination increased with
enhanced muscle mass. Therefore, K68 could serve
as a signalling step. X-linked inhibitor of apoptosis
protein (XIAP) is considered a legitimate inhibitor of
caspases, and cellular IAPs (cIAPs) have been shown
to control NF-κB activation (O’Riordan et al. 2008).
XIAP and cIAP1 conjugate predominantly K63-linked
ubiquitin chains to MEKK2 and MEKK3, which
results in MEK5–ERK5 interaction, leading to ERK5
inactivation. This observation suggests that K63 of IAP
also modulates ERK5–mitogen-activated protein kinase
(MAPK) activation and muscle differentiation (Takeda
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et al. 2014). Therefore, it cannot be ruled out that the
decreases in K48 reflect suppressed degradation and the
increases in K63 indicate signalling that could be linked to
anabolic processes.
SIRT1 activation has been shown to decrease MuRF1
levels in skeletal muscle (Lee & Goldberg, 2013), a finding
that is completely consistent with our current data.
Indeed, a functional link is suggested between SIRT1 and
MuRF1, because the protective effects of resveratrol on
dexamethasone-induced atrogin-1 andMuRF1 expression
was eliminated by SIRT1 silencing (Alamdari et al. 2012).
The increases in MuRF2 levels have been implicated in
muscle growth, which agrees with our findings (Shen et al.
2011).
A number of miRNAs have distinct expression patterns
during muscle differentiation and miRs play regulatory
roles in different pathways associated with myogenesis
(Ge & Chen, 2011) and possibly in muscle hypertrophy
(Rhim et al. 2010). We have identified just a few miRs,
but the decreases in miR-133a in overloaded muscle fit
well with the novel role of SIRT1 in muscle hypertrophy.
The miR133a has binding sites for SIRT1 3′ untranslated
region, and hence it can down-regulate SIRT1 through its
mRNA (Forterre et al. 2014). In our compensatory hyper-
trophy model we found that miR133a levels decreased,
suggesting enhanced production of SIRT1, which we
indeed measured. In addition, the levels of miR133a were
negatively related to Nampt (r2 = −0.93, P < 0.01),
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suggesting a possible role for this miR in the NAD salvage
pathway.
It has been shown that increased levels of miR1 during
atrophy of skeletal muscle reduced HSP70 levels, leading
to decreased phosphorylation of Akt (Kukreti et al. 2013).
In our hypertrophy model, miR1 levels decreased, and we
suggest this may indicate that down-regulation of miR1 is
important to muscle hypertrophy. This is in accordance
with the results of earlier studies (Stantic-Pavlinic &
Grcar-Tratnik, 1986; McCarthy & Esser, 2007) using a
similar model of muscle hypertrophy.
In addition, it appears thatmiR1 andmiR133a are in the
same cluster, which suggests that miR1 can also regulate
SIRT1. Indeed, miR1 has a strong negative correlation
withmusclemass, IGF-1, SIRT1 andNampt (r2=−0.993,
−0.818,−0.889,−0.814, P< 0.05).
miR-214 is present at high concentrations in embryonic
skeletal muscle, but hardly found at all in adult and old
skeletal muscle (Huang et al. 2008), suggesting that it
can play a role in the development of skeletal muscle.
Inhibition of miR-214 in C2C12 cell culture curbed
the differentiation of myoblasts, and down-regulated
levels of myogenin and myosin heavy chain (Feng et al.
2011). Here we detected an almost ten-fold increase in
miR-214 levels,whichcouldbe important in the regulation
of overload-induced proliferation and differentiation of
skeletal muscle. The results of a recent report suggest that
miR-214 can decrease superoxide production via NADPH
oxidase 4 (NOX4) (Ma et al. 2016). This fits nicelywith our
results in which we found a negative correlation between
miR-214 and H2DCFDA fluorescence and NADH levels
(r2 =−0.816,−0.837, P< 0.05), suggesting that miR-214
can modulate the generation of various oxidants during
muscle hypertrophy.
Although IGF-1 and mTOR are target genes for
miR-128, the expression of miR-128 was not changed in
hypertrophied muscle (Chen et al. 2016). One possible
explanation could be the time course as it cannot be
excluded that miR-128 regulation is in the early phase
of adaptive response to the ablation of gastrocnemius and
soleus muscle. This hypothesis is supported by the finding
that this miR has a role in the differentiation of myogenic
satellite cells (Harding & Velleman, 2016), which could be
an early event of compensatory hypertrophy.
Duchene syndrome is a disease associated with
very poor muscle regeneration and hypertrophy and
interestingly the miR26-a levels of these patients are
down-regulated (Eisenberg et al. 2007). The elevation
of miR-26a in the hypertrophied muscle did not reach
statistical significance (P = 0.0632), but the elevation
suggests that this miR could also be involved in hyper-
trophy, probably through the regulation of transforming
growth factor.
It has been suggested that essential amino acids (EAAs)
stimulate muscle protein synthesis in humans. Increased
quantities of EAAs result in increased levels of miR206
andmiR23-a inhuman skeletalmuscle,which is associated
with elevated levels ofMyoD and follistatin, and decreased
levels of myostatin (Drummond et al. 2009), and these
relationships have also been confirmed in the present
study.
Our data are consistent with the hypothesis of a
novel regulatory role for SIRT1 in overload-induced
hypertrophy of skeletal muscle. SIRT1 modulates
prosynthetic pathways through eNOS, Akt activation and
down-regulation of FOXO1 (Fig. 8). The compensatory
hypertrophy of skeletal muscle is regulated by miR1,
miR133a, miR23a, miR34a, miR125b and miR214
through modulation of prosynthetic, catabolic and
apoptotic pathways. Further functional studies will be
needed to directly test our hypothesis that SIRT1 can
regulate overload-induced muscle hypertrophy.
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